/ /

  • linkedin
  • Increase Font
  • Sharebar

    UCLA Stein Eye Institute marks 50th anniversary

    Multiple programs for specialized education, training at core of institute’s mission



    Patient care is the most visible component of the institute, but from the beginning education has also been a top priority. Students from UCLA’s David Geffen School of Medicine learn about ophthalmology and vision science from the institute’s faculty, residents spend three years honing their skills for specialization in ophthalmology, and both clinical and research fellows deepen their understanding of the eye.

    Experienced clinicians turn to the institute for continuing education, and new programs help doctors respond to contemporary challenges.

    The six-year EyeSTAR residency program (“Star” stands for Specialty Training and Advanced Research) is designed to bridge research and clinical care. Residents earn a PhD in vision science when they complete the program.

    The Eye-MBA program is a collaborative effort between the medical school and UCLA’s Anderson School of Management.

    Like education and training, research has been fundamental to the institute’s mission from day one while evolving with the times.

    “Research was always strong here, but there’s a lot more work going on now in vision genetics and stem cells,” Dr. Mondino said. “We were one of the first eye institutes to create a clinical research center to enhance our ability to do translational research.”

    Although the institute has had multiple improvements in its first 50 years, further advances will likely be apparent at the next milestone anniversary. According to Dr. Mondino, one prospect is the development of an entirely new vision campus, the possible outcome of the proposed relocation of the Doheny Eye Institute to Pasadena to be near one of the Doheny Eye Centers.

    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results